Aurinia Pharmaceuticals Inc. - AUPH
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | SVP, Chief Medical Officer | F | D | 8,069.0 | 14.32 | 115,548.08 | 154,449.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | A | A | 67,870.0 | 0.0 | 0.0 | 67,870.0 | View | |
| Mar 03, 2026 | SVP, Chief Medical Officer | A | A | 40,586.0 | 0.0 | 0.0 | 162,518.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | A | A | 328,424.0 | 0.0 | 0.0 | 328,424.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | F | D | 100,890.0 | 14.21 | 1,433,646.9 | 1,840,379.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | A | A | 196,403.0 | 0.0 | 0.0 | 1,941,269.0 | View | |
| Mar 03, 2026 | Chief Operating Officer | A | A | 97,256.0 | 0.0 | 0.0 | 97,256.0 | View | |
| Mar 03, 2026 | Chief Operating Officer | F | D | 40,761.0 | 14.21 | 579,213.81 | 680,299.0 | View | |
| Mar 03, 2026 | Chief Operating Officer | A | A | 58,160.0 | 0.0 | 0.0 | 721,060.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 95,700.0 | 0.0 | 0.0 | 95,700.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | F | D | 37,511.0 | 14.21 | 533,031.31 | 576,421.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 57,229.0 | 0.0 | 0.0 | 613,932.0 | View | |
| Mar 03, 2026 | — | P | A | 184,208.0 | 14.22 | 2,619,437.76 | 12,229,500.0 | View | |
| Mar 03, 2026 | — | P | A | 115,792.0 | 14.21 | 1,645,404.32 | 12,045,292.0 | View | |
| Mar 03, 2026 | — | P | A | 83,561.0 | 14.33 | 1,197,429.13 | 11,929,500.0 | View | |
| Mar 03, 2026 | — | P | A | 1,600.0 | 14.38 | 23,008.0 | 11,845,939.0 | View | |
| Mar 03, 2026 | — | P | A | 214,839.0 | 14.12 | 3,033,526.68 | 11,844,339.0 | View | |
| Mar 03, 2026 | — | P | A | 300,000.0 | 13.9 | 4,170,000.0 | 11,629,500.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 98,813.0 | 0.0 | 0.0 | 98,813.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | F | D | 36,525.0 | 14.21 | 519,020.25 | 505,861.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 59,090.0 | 0.0 | 0.0 | 542,386.0 | View | |
| Feb 23, 2026 | Chief Financial Officer | F | D | 32,424.0 | 14.4 | 466,905.6 | 556,703.0 | View | |
| Feb 23, 2026 | EVP, General Counsel | F | D | 34,638.0 | 14.4 | 498,787.2 | 483,296.0 | View | |
| Feb 23, 2026 | Chief Executive Officer | F | D | 100,171.0 | 14.4 | 1,442,462.4 | 1,744,866.0 | View | |
| Feb 23, 2026 | Chief Operating Officer | F | D | 32,901.0 | 14.4 | 473,774.4 | 662,900.0 | View | |
| Feb 03, 2026 | SVP, Chief Medical Officer | F | D | 11,552.0 | 14.53 | 167,850.56 | 121,932.0 | View | |
| Jan 05, 2026 | Chief Executive Officer | F | D | 113,169.0 | 15.95 | 1,805,045.55 | 1,845,037.0 | View | |
| Jan 05, 2026 | Chief Executive Officer | A | A | 165,384.0 | 0.0 | 0.0 | 1,954,329.0 | View | |
| Jan 05, 2026 | Chief Financial Officer | F | D | 40,161.0 | 15.95 | 640,567.95 | 589,127.0 | View | |
| Jan 05, 2026 | Chief Financial Officer | A | A | 49,038.0 | 0.0 | 0.0 | 626,399.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | F | D | 42,787.0 | 15.95 | 682,452.65 | 695,801.0 | View | |
| Jan 05, 2026 | Chief Operating Officer | A | A | 54,166.0 | 0.0 | 0.0 | 734,631.0 | View | |
| Jan 05, 2026 | EVP, General Counsel | F | D | 40,385.0 | 15.95 | 644,140.75 | 517,934.0 | View | |
| Jan 05, 2026 | EVP, General Counsel | A | A | 48,558.0 | 0.0 | 0.0 | 557,434.0 | View | |
| Nov 24, 2025 | — | F | D | 2,716.0 | 15.68 | 42,586.88 | 22,775.0 | View | |
| Nov 24, 2025 | — | F | D | 6,039.0 | 15.68 | 94,691.52 | 14,592.0 | View |